Dublin, May 21, 2025 (GLOBE NEWSWIRE) -- The "Gene Expression Analysis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's offering.
The Gene Expression Analysis Market was valued at USD 5.02 Billion in 2024 and is projected to reach USD 7.84 Billion by 2030, rising at a CAGR of 7.71%.
A key growth factor is the rising demand for personalized treatment approaches, where gene expression profiling helps identify individual genetic signatures, enabling more precise and effective therapies.
Technological advancements, particularly in high-throughput sequencing platforms like RNA-Seq, have significantly enhanced researchers' ability to investigate the transcriptome at an unprecedented scale. The adoption of these technologies has fueled a surge in biomedical research and collaboration among pharmaceutical firms, diagnostic developers, and research institutions. In oncology, gene expression tools are increasingly used to discover biomarkers and predict treatment responses, further accelerating the expansion of the market.
Key Market Driver: Advancements in Sequencing Technologies
Technological progress in sequencing has been a critical driver of the Global Gene Expression Analysis Market. Next-generation sequencing (NGS), in particular, has transformed gene expression studies by offering high-throughput capabilities, greater sensitivity, and cost efficiency. NGS enables the simultaneous examination of thousands of genes across numerous samples, providing deeper insights into gene activity and regulation.
These capabilities have broadened the use of gene expression profiling in personalized medicine, disease diagnostics, and fundamental research. The launch of high-capacity sequencers like Illumina's NovaSeq X Series, which can process over 20,000 whole genomes annually, exemplifies how enhanced throughput and reduced costs are making transcriptome analysis more accessible and widespread. This technological evolution is reshaping genomic research and reinforcing the market's long-term growth trajectory.
Key Market Challenge: Data Analysis Complexities
One of the significant hurdles in the Global Gene Expression Analysis Market is the complexity involved in managing and interpreting large-scale gene expression data. High-throughput methods, such as RNA-Seq, generate vast volumes of data that require sophisticated bioinformatics tools and computational infrastructure for effective analysis. The necessity for robust data processing pipelines - from quality control and alignment to normalization and differential expression analysis - adds layers of technical difficulty.
Missteps at any stage can lead to inaccurate conclusions, undermining research validity. Additionally, the requirement for high-performance computing resources and specialized data analytics expertise presents a cost and skill barrier for many institutions, especially smaller laboratories and emerging markets. Addressing these analytical challenges is vital for maximizing the utility and reliability of gene expression studies.
Key Market Trend: Single-Cell RNA Sequencing (scRNA-Seq)
A prominent trend in the Global Gene Expression Analysis Market is the growing use of Single-Cell RNA Sequencing (scRNA-Seq). This cutting-edge technique enables researchers to profile gene expression at the individual cell level, revealing cellular heterogeneity that is otherwise masked in bulk RNA analyses.
scRNA-Seq is transforming areas such as cancer biology, immunology, neuroscience, and developmental biology by allowing precise characterization of rare cell types and cellular states. This capability is driving a deeper understanding of disease mechanisms, progression, and treatment resistance. The rise of scRNA-Seq reflects a broader shift toward high-resolution, data-rich research tools that support more accurate and personalized scientific discoveries.
Key Players Profiled in this Gene Expression Analysis Market Report
- Merck KGaA
- Genscript Biotech Corporation
- Qiagen
- Bio-Rad Laboratories
- Takara Bio Inc.
- Thermo Fisher Scientific, Inc.
- Promega Corporation
- Agilent Technologies
- Lonza Group Ltd.
- New England Biolabs Inc
Report Scope
In this report, the Global Gene Expression Analysis Market has been segmented into the following categories:
Gene Expression Analysis Market, by Product Type:
- Instruments
- Services
- Others
Gene Expression Analysis Market, by Technique:
- RNA Expression
- Promotor Analysis
- Protein Expression & Post Translational Modification Expression
- Others
Gene Expression Analysis Market, by Application:
- Drug Discovery and Development
- Clinical Diagnostics
- Biotechnology and Microbiology
- Others
Gene Expression Analysis Market, by End User:
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic and Government Research Institutes
- Others
Gene Expression Analysis Market, by Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Key Attributes
| Report Attribute | Details |
| No. of Pages | 185 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $5.02 Billion |
| Forecasted Market Value (USD) by 2030 | $7.84 Billion |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/22vgfm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
